Skip to content
StockMarketAgent
Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

SHE/301257 stock hub

SHE/301257 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHE/301257is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
4.2B
Shenzhen Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHE/301257
In the news

Latest news · SHE/301257

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 17.1P50 24.2P75 37.8
Trailing P/E36.7
P25 23.5P50 41.3P75 83.2
ROE9.3
P25 -0.9P50 4.1P75 8.8
ROIC18.1
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHE/301257 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
215
Groups with data
11
Currency
CNY
Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
China
Country code
CN
Employees
4,271
Employees Change
-145%
Employees Change Percent
-3.28
Enterprise value
CNY 3.6B
Exchange
Shenzhen Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Diagnostics & Research
Isin
CNE100005CP8
Last refreshed
2026-05-10
Market cap
CNY 4.2B
Price
CNY 53.18
Price currency
CNY
Rev Per Employee
201,373.72x
Sector
Healthcare
Sic
8731
Symbol
she/301257
Website
https://www.smo-clinplus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

12
MetricValue
Earnings Yield
2.72%
EV Earnings
31.75x
EV/EBIT
26.42x
EV/EBITDA
24.89x
EV/FCF
117.91x
EV/Sales
4.22x
FCF yield
0.73%
P/B ratio
3.28x
P/E ratio
36.71x
P/S ratio
4.89x
PE Ratio3 Y
27.87x
PE Ratio5 Y
32.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
15.96%
EBITDA Margin
16.83%
FCF margin
3.58%
Gross margin
25.7%
Gross Profit
CNY 221M
Gross Profit Growth
11.21%
Gross Profit Growth Q
23.37%
Gross Profit Growth3 Y
10.86%
Gross Profit Growth5 Y
17.42%
Net Income
CNY 114.2M
Net Income Growth
3.02%
Net Income Growth Q
-34.86%
Net Income Growth3 Y
14.83%
Net Income Growth5 Y
25.43%
Pretax Margin
15.43%
Profit Margin
13.28%
Profit Per Employee
CNY 26,746
ROA
5.83
Roa5y
6.79
ROCE
10.7
ROE
9.28
Roe5y
14.66
ROIC
18.1
Roic5y
49.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

16
MetricValue
Cagr1y
87.53%
Cagr3y
-3.49%
EPS Growth
2.22
EPS Growth Q
-7.06
EPS Growth3 Y
10.49
EPS Growth5 Y
17.98
FCF Growth Q
-29.58%
FCF Growth3 Y
-4.99%
FCF Growth5 Y
8.7%
OCF Growth Q
-17.59%
OCF Growth3 Y
-4.07%
OCF Growth5 Y
9.72%
Revenue Growth
4.82x
Revenue Growth Q
11.15x
Revenue Growth3 Y
12.85x
Revenue Growth5 Y
20.23x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
CNY 0.58
Assets
CNY 1.5B
Cash
CNY 578.7M
Current Assets
CNY 1.3B
Current Liabilities
CNY 273.8M
Debt
CNY 4.4M
Debt EBITDA
CNY 0.03
Debt Equity
CNY 0
Debt FCF
CNY 0.14
Equity
CNY 1.3B
Liabilities
CNY 243.4M
Long Term Assets
CNY 203.4M
Long Term Liabilities
CNY -30.4M
Net Cash
CNY 574.4M
Net Cash By Market Cap
CNY 13.67
Net Cash Growth
-30.55%
Net Debt EBITDA
CNY -3.97
Net Debt Equity
CNY -0.45
Net Debt FCF
CNY -18.67
Tangible Book Value
CNY 1.3B
Tangible Book Value Per Share
CNY 15.97
WACC
9.72

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
4.99
Net Working Capital
CNY 392.5M
Quick ratio
4.98
Working Capital
CNY 967.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-0.78%
Dividend Growth
-46.84%
Dividend Growth Years
0%
Dividend per share
CNY 0.27
Dividend Years
3
Dividend Yield
0.5%
Ex Div Date
2025-11-28
Last Dividend
CNY 0.07
Payout Frequency
Semi-Annual
Payout Ratio
11.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
87.45%
200-day SMA
51.47
3Y total return
-10.12%
50-day SMA
58.64
50-day SMA vs 200-day SMA
50over200
All Time High
85
All Time High Change
-37.44%
All Time High Date
2026-01-14
All Time Low
23.07
All Time Low Change
130.52%
All Time Low Date
2024-08-28
ATR
2.67
Beta
1
Beta1y
0.67
Beta2y
0.94
Ch YTD
2.19
High
53.64
High52
85
High52 Date
2026-01-14
High52ch
-37.44%
Low
51.72
Low52
27.2
Low52 Date
2025-05-15
Low52ch
95.52%
Ma50ch
-9.3%
Price vs 200-day SMA
3.33%
RSI
38.81
RSI Monthly
56.18
RSI Weekly
47.43
Sharpe ratio
1.25x
Sortino ratio
2.41
Total Return
-0.27%
Tr YTD
2.19
Tr1m
-12.76%
Tr1w
0.42%
Tr3m
-23.32%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
CNY 137.3M
Operating Income Growth
16.73
Operating Income Growth Q
28.1
Operating Income Growth3 Y
25.03
Operating Income Growth5 Y
28.68
Operating margin
15.96

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
46,187,261%
Shares Insiders
14.83%
Shares Institutions
16.08%
Shares Out
79,004,770
Shares Qo Q
3.07%
Shares Yo Y
0.78%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

59
MetricValue
Adjusted FCF
CNY 30.8M
Average Volume
2,144,292.15x
Bv Per Share
15.99
CAPEX
CNY -9.4M
Ch1m
-12.76
Ch1w
0.42
Ch1y
86.53
Ch3m
-23.32
Ch3y
-11.62
Ch6m
12.36
Change
0%
Change From Open
0
Close
53.18
Days Gap
0
Depreciation Amortization
7,046,071
Dollar Volume
93,722,996.1
Earnings Date
2026-04-29
EBIT
CNY 137.3M
EBITDA
CNY 144.7M
EPS
CNY 1.45
F Score
4
FCF
CNY 30.8M
FCF EV Yield
0.85x
FCF Per Share
CNY 0.39
Financing CF
-54,224,163
Fiscal Year End
December
Founded
2,009
Graham Number
22.82852
Graham Upside
-57.07
Income Tax
CNY 18.5M
Investing CF
-120,959,568
Is Primary Listing
1
Last Earnings Date
2026-04-29
Last Report Date
2025-12-31
Last Split Date
2024-06-06
Last Split Type
Forward
Lynch Fair Value
CNY 36.22
Lynch Upside
-31.89
Ma150
54.82
Ma150ch
-2.99%
Ma20
56.8
Ma20ch
-6.38%
Net CF
-135,015,985
Next Earnings Date
2026-08-28
Open
53.18
P FCF Ratio
136.6
P OCF Ratio
104.6
Payment Date
2025-11-28
Position In Range
76.04
Ppne
44,033,288
Price Date
2026-05-08
Price EBITDA
CNY 29.03
Ptbv Ratio
3.28
Relative Volume
0.82x
Revenue
860,067,138x
Tax By Revenue
2.15x
Tax Rate
13.93%
Tr6m
12.53%
Volume
1,762,373
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

SHE/301257 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.5%
$0.27 annual per share
Payout ratio
+11.6%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
0 consecutive years of growth
Total shareholder yield
-0.3%
Next ex-dividend date: 2025-11-28
Performance

SHE/301257 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+87.4%
S&P 500 1Y: n/a
3Y total return
-10.1%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns SHE/301257?

Insider, institutional, and short-interest positioning.

Institutional ownership
+16.1%
Share of float held by funds and institutions
Insider ownership
+14.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.8%
Negative means the company is buying back shares.
Technical

SHE/301257 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
38.8
Neutral momentum band
Price vs 200-day MA
+3.3%
50/200-day relationship not available
Beta (5Y)
1.00
Moves roughly with the market
Sharpe ratio
1.25
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHE/301257

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/301257 stock rating?

she/301257 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/301257 analysis?

The full report lives at /stocks/she/301257/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/301257?

The latest report frames she/301257 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/301257 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

she/301257 stock profile: metrics, valuation and analysis | Aktienmarkt-Agent KI